Ian Leitch

Director of Clinical Research at Opthea - South Yarra, VIC, AU

Ian Leitch's Colleagues at Opthea
Annette Leahy

Director Clinical Research

Contact Annette Leahy

Clare Price

Director of Clinical Development

Contact Clare Price

Jeremy Levin

Chairman Of The Board

Contact Jeremy Levin

Mark Oneill

Technical Development

Contact Mark Oneill

View All Ian Leitch's Colleagues
Ian Leitch's Contact Details
HQ
61-3-9826-0399
Location
Melbourne, Victoria, Australia
Company
Opthea
Ian Leitch's Company Details
Opthea logo, Opthea contact details

Opthea

South Yarra, VIC, AU • 20 - 49 Employees
BioTech/Drugs

Opthea is a clinical stage biopharmaceutical company committed to developing innovative therapies to help improve visual function in patients suffering with retinal diseases. Our first in class novel therapeutic called OPT-302, is a VEGF-C/D ‘trap', to be used in combination with existing standard of care anti-VEGF-A therapies to improve vision in patients, many of whom respond sub-optimally or become refractory to existing treatments. Millions of people around the world suffer from impaired vision as a result of diabetes and old age. Our mission is to improve vision leading to a better quality of life. Enquiries can be directed to: info@opthea.com

Ophthalmological drug development
Details about Opthea
Frequently Asked Questions about Ian Leitch
Ian Leitch currently works for Opthea.
Ian Leitch's role at Opthea is Director of Clinical Research.
Ian Leitch's email address is ***@opthea.com. To view Ian Leitch's full email address, please signup to ConnectPlex.
Ian Leitch works in the BioTech/Drugs industry.
Ian Leitch's colleagues at Opthea are Gary Menichini, Annette Leahy, Clare Price, Jeremy Levin, Judy Robertson, Mike Gerometta, Mark Oneill and others.
Ian Leitch's phone number is 61-3-9826-0399
See more information about Ian Leitch